ArticleGene therapy2013

Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.

J Nemunaitis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.